Expert Review of Vaccines
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 77.6% | 1.280 | Q1 | 89.4% |
| 2024 | 4.8 | Q2 | 75.0% | 1.255 | Q1 | 89.3% |
| 2023 | 5.5 | Q1 | 75.5% | 1.412 | Q1 | 91.9% |
| 2022 | 6.2 | Q2 | 72.9% | 1.346 | Q1 | 91.6% |
| 2021 | 5.7 | Q2 | 63.5% | 1.689 | Q1 | 94.4% |
| 2020 | — | — | 1.864 | Q1 | 94.9% | |
| 2019 | — | — | 1.746 | Q1 | 94.4% | |
| 2018 | — | — | 1.603 | Q1 | 92.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-8395
ISSN
1476-0584
region
Western Europe
coverage
2002-2026